Search by Drug Name or NDC
NDC 67618-0120-06 Senokot 17.2 mg/1 Details
Senokot 17.2 mg/1
Senokot is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Atlantis Consumer Healthcare, Inc.. The primary component is SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 67618-0120-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 67618-0120 |
|---|---|
| Product ID | 67618-120_b2a10442-8af0-416a-b6b7-1a836420717e |
| Associated GPIs | 46200060200318 |
| GCN Sequence Number | 060282 |
| GCN Sequence Number Description | sennosides TABLET 17.2MG ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 26397 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Brand |
| Proprietary Name | Senokot |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | standardized senna concentrate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 17.2 |
| Active Ingredient Units | mg/1 |
| Substance Name | SENNOSIDES |
| Labeler Name | Atlantis Consumer Healthcare, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M007 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 67618-0120-06 (67618012006)
| NDC Package Code | 67618-120-06 |
|---|---|
| Billing NDC | 67618012006 |
| Package | 36 TABLET, FILM COATED in 1 BOTTLE (67618-120-06) |
| Marketing Start Date | 1988-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |